30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Ahrens Brenton Karl

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 83% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ahrens Brenton Karl's trades of Iterum Therapeutics PLC's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-20 2022-09-20
S Sale
28,356 +25.4%
360.78
US$2,549,065 		28,356 +25.4% 360.78 US$2,549,065
2022-09-20 2022-09-19
S Sale
20,191 -48.0%
388.65
US$2,757,496 		20,191 -48.0% 388.65 US$2,757,496
2022-09-20 2022-09-16
S Sale
15,487 -4.1%
480.70
US$3,752,678 		15,487 -4.1% 480.70 US$3,752,678
2022-09-15 2022-09-15
S Sale
15,000 -28.7%
2.02
US$30,272 		15,000 -28.7% 2.02 US$30,272
2022-09-15 2022-09-14
S Sale
15,000 -22.3%
2.10
US$31,456 		15,000 -22.3% 2.10 US$31,456
2022-09-15 2022-09-13
S Sale
15,000 -18.2%
2.14
US$32,118 		15,000 -18.2% 2.14 US$32,118
2022-09-12 2022-09-12
S Sale
15,000 -15.4%
2.31
US$34,608 		15,000 -15.4% 2.31 US$34,608
2022-09-12 2022-09-09
S Sale
15,000 -13.4%
2.32
US$34,730 		15,000 -13.4% 2.32 US$34,730
2022-09-12 2022-09-08
S Sale
3,298 -2.9%
2.26
US$7,465 		3,298 -2.9% 2.26 US$7,465